
doi: 10.1002/pbc.22624
pmid: 20979174
A 26-month-old male presented with bone marrow failure and dystrophic nail lesions mimicking onychomycosis. There was no skin finding. Treatment with androgen and methylprednisolone was started due to unavailability of a matched-related hematopoietic stem cell donor. After 30 months, transfusion support was required. TINF2 mutation was identified at the age of five and dyskeratosis congenita (DC) was confirmed. TIN2 mutation analysis must be carried out in patients younger than 10 years presenting with bone marrow failure even if characteristic physical anomalies of DC is missing. Genetic confirmation of DC prevents ineffective immunotherapy with misdiagnosis of acquired aplastic anemia.
Male, Telomere-Binding Proteins, Anti-Inflammatory Agents, Methylprednisolone, Dyskeratosis Congenita, Shelterin Complex, Drug Combinations, Child, Preschool, Mutation, Androgens, Humans, Bone Marrow Diseases
Male, Telomere-Binding Proteins, Anti-Inflammatory Agents, Methylprednisolone, Dyskeratosis Congenita, Shelterin Complex, Drug Combinations, Child, Preschool, Mutation, Androgens, Humans, Bone Marrow Diseases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
